Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

3D Culture Models with CRISPR Screens Reveal Hyperactive NRF2 as a Prerequisite for Spheroid Formation via Regulation of Proliferation and Ferroptosis
Nobuaki Takahashi, Patricia Cho, Laura M. Selfors, et al.
Molecular Cell (2020) Vol. 80, Iss. 5, pp. 828-844.e6
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
Brent R. Stockwell
Cell (2022) Vol. 185, Iss. 14, pp. 2401-2421
Open Access | Times Cited: 1658
Cancer metabolism: looking forward
Inmaculada Martínez‐Reyes, Navdeep S. Chandel
Nature reviews. Cancer (2021) Vol. 21, Iss. 10, pp. 669-680
Closed Access | Times Cited: 1223
Characteristics and Biomarkers of Ferroptosis
Xin Chen, Paul B. Comish, Daolin Tang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 361
Kaempferol Ameliorates Oxygen-Glucose Deprivation/Reoxygenation-Induced Neuronal Ferroptosis by Activating Nrf2/SLC7A11/GPX4 Axis
Yuan Yuan, Yanyu Zhai, Jingjiong Chen, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 923-923
Open Access | Times Cited: 295
A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers
Pranavi Koppula, Guang Lei, Yilei Zhang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 281
The cell biology of ferroptosis
Scott J. Dixon, James A. Olzmann
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 424-442
Closed Access | Times Cited: 271
Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity
Bartosz Wiernicki, Sophia Maschalidi, Jonathan J. Pinney, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 213
GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment
Yi Liu, Yicong Wan, Yi Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188890-188890
Closed Access | Times Cited: 204
Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2/GPX4 defense pathway
Minghao Ge, He Tian, Liang Mao, et al.
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 9, pp. 1023-1040
Open Access | Times Cited: 183
SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis
Lei Feng, Kaikai Zhao, Liangchao Sun, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 177
Ferroptosis-Related Long Non-Coding RNA signature predicts the prognosis of Head and neck squamous cell carcinoma
Yun Tang, Cheng Li, Youjing Zhang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 3, pp. 702-711
Open Access | Times Cited: 137
Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance
Patrizia Romani, Nunzia Nirchio, Mattia Arboit, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 2, pp. 168-180
Open Access | Times Cited: 135
CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement
Chao Li, Eleanor J. Brant, Hikmet Budak, et al.
Journal of Zhejiang University SCIENCE B (2021) Vol. 22, Iss. 4, pp. 253-284
Open Access | Times Cited: 131
NRF2: KEAPing Tumors Protected
Ray Pillai, Makiko Hayashi, Anastasia‐Maria Zavitsanou, et al.
Cancer Discovery (2022) Vol. 12, Iss. 3, pp. 625-643
Open Access | Times Cited: 119
GPX4-independent ferroptosis—a new strategy in disease’s therapy
Tianyu Ma, Jingtong Du, Yufeng Zhang, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 107
Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability
Zhipeng Li, Lucas Ferguson, Kirandeep K. Deol, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 7, pp. 751-761
Open Access | Times Cited: 79
Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation
Fabienne Müller, Jonathan K.M. Lim, Christina M. Bebber, et al.
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 442-456
Open Access | Times Cited: 79
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Ziad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Cell Reports (2022) Vol. 38, Iss. 1, pp. 110190-110190
Open Access | Times Cited: 75
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
Giovanni C. Forcina, Lauren Pope, Magdalena Murray, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 11
Open Access | Times Cited: 72
Ferroptosis in health and disease
Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Redox Biology (2024) Vol. 75, pp. 103211-103211
Open Access | Times Cited: 65
The pleiotropic functions of reactive oxygen species in cancer
Katherine Wu, Ahmed E. El Zowalaty, Volkan I. Sayin, et al.
Nature Cancer (2024) Vol. 5, Iss. 3, pp. 384-399
Closed Access | Times Cited: 58
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
Solveigh C. Koeberle, Anna P. Kipp, Hermann Stuppner, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 3, pp. 614-682
Open Access | Times Cited: 54
Regulation of antioxidants in cancer
Fábio Hecht, Marco Zocchi, Fatemeh Alimohammadi, et al.
Molecular Cell (2023) Vol. 84, Iss. 1, pp. 23-33
Open Access | Times Cited: 46
The Role of Oxidative Stress in Tumorigenesis and Progression
Kexin Li, Zhangyuzi Deng, Chunran Lei, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 441-441
Open Access | Times Cited: 20
Thirty years of NRF2: advances and therapeutic challenges
Donna D. Zhang
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top